Search the Newsreel

Lexeo Therapeutics Inc (LXEO) Dividends & Stock Splits: Historical Payouts and Event Timeline

This article provides an overview of Lexeo Therapeutics Inc (LXEO) stock information, focusing on its dividend and stock split history. It notes that no dividend data is available, with zero dollars distributed over the past five years. The page also presents current trading information …

Earnings To Watch: Expand Energy (EXE) Reports Q2 Results Tomorrow

Lexeo Therapeutics, Inc. $LXEO Shares Sold by Octagon Capital Advisors LP

Orbimed Advisors LLC Purchases 1,477,450 Shares of Lexeo Therapeutics, Inc. $LXEO

Exelixis, Inc. Revenue Breakdown – BX:EX9

The article provides a revenue breakdown for Exelixis, Inc. (BX:EX9), highlighting that the company generated 1.84 billion CHF in its last fiscal year from its top segment, "Medicines for Difficult-to-treat Cancers." The United States was the greatest contributor to this revenue, accounting for 1.70 …

Exelixis Inc (EXEL) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Exelixis Inc (EXEL), categorizing it by business segments and geographical regions. CABOMETYX is highlighted as the dominant revenue source, contributing over 91% of the total, followed by license revenues. The United States accounts for the vast …

Exelixis Inc (EXEL) Shareholder Structure: Major Shareholders & Institutional Holdings

This article provides an overview of Exelixis Inc (EXEL) shareholder structure, detailing major institutional holdings and shareholder types. It lists top shareholders like BlackRock and Farallon Capital, their proportion of shares, and changes in their holdings over time. The document also includes a historical …

Exelon stock trades steadily as regulated earnings and clean energy investments shape outlook

Exelon stock is driven by the stable cash flows of its regulated utility business and its focus on clean energy investments. Investors closely monitor earnings trends, capital spending, dividend capacity, and regulatory decisions that influence the company's financial performance and future growth. Exelon's balance …

White & Case advises Expand Energy on US$1.25 billion acquisition of Twin Eagle

White & Case LLP advised Expand Energy Corporation on its US$1.25 billion acquisition of Twin Eagle Holdings, N.A., LLC. This transaction will create a fully integrated natural gas company by combining Expand Energy's supply and financial strength with Twin Eagle's physical marketing platform. The …

Latham & Watkins Advises Twin Eagle and Five Point Infrastructure in Acquisition by Expand Energy Corporation

Latham & Watkins LLP advised Twin Eagle and Five Point Infrastructure in the acquisition of Twin Eagle Holdings N.A., LLC by Expand Energy Corporation for US$1.25 billion. This transaction aims to create North America's leading integrated natural gas company. The deal, which involved a …

Lexeo Therapeutics Inc (LXEO) Income Statement

This article presents the quarterly and annual income statements for Lexeo Therapeutics Inc (LXEO), offering detailed financial data such as revenue, operating expenses, and net income from Q1 2022 through Q1 2026. It highlights the company's financial performance and includes FAQs to guide users …

EXEL|Exelixis Inc|Price:55.370|Chg%:-0.280

Exelixis Inc (EXEL) is an oncology company with strong fundamentals and high growth potential, though its stock performance has been average over the past month. The company's valuation is considered fair, and it has a high institutional ownership. Analysts generally rate EXEL as a …

Expand Energy to Acquire Twin Eagle for $1.25B | EXE Stock News

Expand Energy (NASDAQ: EXE) has announced a definitive agreement to acquire Twin Eagle Holdings for $1.25 billion, funded by cash on hand and its revolving credit facility. The acquisition aims to create North America's leading integrated natural gas company, combining Expand's production with Twin …

Expand Energy Corporation Revenue Breakdown – NASDAQ:EXE

Crexendo Inc (CXDO) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Crexendo Inc (CXDO), listing major individual and institutional holders and their respective proportions. It also breaks down shareholder types and provides a history of institutional shareholding over recent quarters, alongside related ETF information.

Crexendo Inc (CXDO) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution

This article provides a detailed revenue breakdown for Crexendo Inc (CXDO) by business segment and geographical region. It highlights that telecommunications services and subscription maintenance and support are the largest revenue contributors, and the United States accounts for the vast majority of the company's …

Lexeo Therapeutics Inc (LXEO) Valuation: PE, PB & Fair Value Analysis

This article provides a valuation analysis for Lexeo Therapeutics Inc (LXEO), noting its current valuation score of 6.63, which ranks it 313 out of 386 in the Biotechnology & Medical Research industry. The company's P/E ratio is reported as -4.14, while relevant data for …

LXEO|Lexeo Therapeutics Inc|Price:4.660|Chg%:-0.050

This article provides a detailed stock analysis of Lexeo Therapeutics Inc (LXEO), highlighting its fundamentals, growth potential, and valuation. The company has weak fundamentals but high growth potential, and its stock is considered fairly valued within the Biotechnology & Medical Research industry. Analysts have …

Exelon Corp (EXC) Risk Assessment: Volatility, Financial Risk & Investment Risk

This article provides a risk assessment for Exelon Corp (EXC), highlighting its current risk score and ranking within the Electric Utilities & IPPs industry. It details various risk metrics such as beta, VaR, maximum drawdown, and volatility, indicating the stock's performance characteristics relative to …

Exelon Corp (EXC) Valuation: PE, PB & Fair Value Analysis

This article analyzes Exelon Corp's (EXC) valuation metrics, noting a current valuation score of 6.16, placing it 54th out of 63 in its industry. The company's P/E ratio is 17.38, which is below its recent high and above its recent low. Key valuation ratios …

Lexeo Therapeutics Inc (LXEO) Risk Assessment: Volatility, Financial Risk & Investment Risk

Lexeo Therapeutics Inc (LXEO) has a current risk assessment score of 4.33, ranking 84 out of 386 in the Biotechnology & Medical Research industry. The company's beta value is 0.00, indicating it tends to underperform during upward markets but decline less during downward markets. …

Exelon stock trades steady as regulated earnings and nuclear fleet underpin cash flows

Exelon (ISIN US30161N1019) is a leading regulated electric and gas utility holding company in the United States, whose stock performance is bolstered by stable earnings from its regulated distribution businesses and robust cash flow generation from its large nuclear fleet. The company's financial strength …

Affinity Asset Advisors LLC Increases Stock Position in Lexeo Therapeutics, Inc. $LXEO

Extendicare Inc. Revenue Breakdown – TSX:EXE

Exelon Corp. (EXC) Earnings Dates, Call Summary & Reports

This article provides detailed earnings information for Exelon Corp. (EXC), including upcoming earnings dates, historical performance, and analyst consensus. Exelon is scheduled to report its Q2 2026 earnings before market open on July 30, 2026, with a consensus EPS forecast of 7.73. The article …

Crexendo, Inc. Revenue Breakdown – NASDAQ:CXDO

This article provides a detailed revenue breakdown for Crexendo Inc (CXDO) by business segment and geographical region. It highlights that telecommunications services and subscription maintenance and support are the largest revenue contributors, and the United States accounts for the vast majority of the company's …

Exelon Corp (EXC) Shareholder Structure: Major Shareholders & Institutional Holdings

This article details the shareholder structure of Exelon Corp (EXC), outlining major institutional holders like BlackRock, State Street, and Vanguard, and their respective proportions. It also presents a breakdown of shareholder types, including investment advisors, pension funds, and hedge funds. Furthermore, the article provides …

EXE|Expand Energy Corp|Price:94.720|Chg%:-1.560

Exelon (EXC) Time Of Day Pricing Launch Puts Valuation Back In Focus

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Exelon (EXC) is drawing fresh attention after its Illinois utility, ComEd, launched a Time-of-Day Pricing program and as investors look ahead to the company's …

Expand Energy to Report Q2 Earnings: What's in the Offing?

Expand Energy Corporation EXE is set to release second-quarter 2026 earnings on July 28. The Zacks Consensus Estimate for the to-be-reported quarter is pegged at a profit of $1.16 per share on revenues of $2.01 billion. Let us delve into the factors that might …

EXC|Exelon Corp|Price:47.348|Chg%:+0.068

Exelon Corp (EXC) shows stable fundamentals and high growth potential, with its valuation considered fairly valued within the Electric Utilities & IPPs industry. Institutional ownership is high, and analysts largely rate it as "Hold" with a target price of $49.24. The company exhibits strong …

EXEL Maintained by Morgan Stanley -- Price Target Raised to $53

Morgan Stanley has maintained an Equal-Weight rating on Exelixis (EXEL) while raising its price target from $50.00 to $53.00, an increase of 6%. Despite this cautious optimism, GuruFocus assesses EXEL as 29.1% overvalued with a GF Value™ of $42.86 against its current price of …

EXC|Exelon Corp|Price:47.280|

Exelon Corp's fundamentals are stable with high growth potential, and its valuation is considered fair within the Electric Utilities & IPPs industry. The stock has high institutional ownership and analysts generally rate it as a "Hold" with a target price of $49.24. Despite average …

Exelon Corp. stock outperforms competitors on strong trading day

Exelon Corp. (EXC) stock rallied 1.24% to $47.28 on Thursday, outperforming the broader market which saw the S&P 500 Index and Dow Jones Industrial Average decline. This marked the second consecutive day of gains for Exelon, occurring during an overall poor trading session for …

Exelon Corp (EXC) Technical Analysis: Support, Resistance, Indicators & Moving Averages

This article provides a technical analysis of Exelon Corp (EXC), focusing on its current price momentum, support and resistance levels, and various technical indicators. The stock currently has a price momentum score of 2.32 and is trading between a resistance level of $48.71 and …

Exelon (EXC) to Release Quarterly Earnings on Thursday